Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 27, 2019 07:00 ET | Source: Antares Pharma, Inc.

Antares Pharma to Present at the Raymond James & Associates 40th Annual Institutional Investors Conference

EWING, N.J., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Raymond James...
February 25, 2019 17:00 ET | Source: Antares Pharma, Inc.

Antares Pharma to Report Fourth Quarter and Full Year 2018 Financial and Operating Results

EWING, N.J., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its fourth quarter and full year 2018 financial results and recent operating...
December 13, 2018 07:00 ET | Source: Antares Pharma, Inc.

Antares Pharma Announces the Appointment of Peter S. Greenleaf to Company’s Board of Directors

EWING, N.J., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced the appointment of Peter S. Greenleaf to the Company’s Board of Directors. Mr. Greenleaf has over...
November 29, 2018 07:00 ET | Source: Antares Pharma, Inc.

Antares Pharma Announces the Commercial Availability of XYOSTED™ (Testosterone Enanthate) Injection — A New Treatment for Adult Men Diagnosed With Testosterone Deficiency

EWING, N.J., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced the availability of XYOSTED™ (testosterone enanthate) injection. XYOSTED™ is the only FDA approved...
November 27, 2018 10:36 ET | Source: Antares Pharma, Inc.

Antares Pharma Partner Teva Announces Commercial Availability of Generic Epipen®

EWING, N.J., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“Antares”) today announced that Teva Pharmaceutical Industries, Ltd.’s (“Teva”) generic EpiPen® is now...
November 26, 2018 07:30 ET | Source: Antares Pharma, Inc.

Antares Pharma to Present at the 30th Annual Piper Jaffray Healthcare Conference

EWING, N.J., Nov. 26, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the 30th Annual Piper...
November 09, 2018 07:00 ET | Source: Antares Pharma, Inc.

Antares Pharma Announces Data Presentation at the 2018 Sexual Medicine Society Scientific Annual Meeting

XYOSTED™ AMBULATORY BLOOD PRESURE ABSTRACT HAS BEEN SELECTED FOR POSTER PRESENTATION EWING, N.J., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced that data...
November 08, 2018 07:00 ET | Source: Antares Pharma, Inc.

Antares Pharma to Present at the Jefferies 2018 Global Healthcare Conference

EWING, N.J., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Jefferies 2018...
November 06, 2018 07:00 ET | Source: Antares Pharma, Inc.

Antares Pharma Reports Third Quarter 2018 Operating and Financial Results

The Company Posts Record Quarterly Revenue Of $17.9 Million EWING, N.J., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (the Company) today announced operating and financial...
October 30, 2018 07:00 ET | Source: Antares Pharma, Inc.

Antares Pharma to Report Third Quarter 2018 Financial and Operating Results

EWING, N.J., Oct. 30, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its third quarter 2018 financial results and recent operating progress before the...